4//SEC Filing
Manion Douglas J. 4
Accession 0001209191-24-000416
CIK 0001557746other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:44 PM ET
Size
9.2 KB
Accession
0001209191-24-000416
Insider Transaction Report
Form 4
Manion Douglas J.
Pres and COO
Transactions
- Exercise/Conversion
Common Stock
2024-01-01+27,000→ 50,938 total - Exercise/Conversion
Restricted Stock Units
2024-01-01−27,000→ 81,000 total→ Common Stock (27,000 underlying) - Tax Payment
Common Stock
2024-01-01$1.05/sh−9,125$9,581→ 41,813 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.
- [F3]On February 1, 2023, the Reporting Person was granted 108,000 restricted stock units. The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of January 1, 2023, subject to the Continuous Service of the Reporting Person (as defined in the Plan) as of each such date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001875875
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:44 PM ET
- Size
- 9.2 KB